Comparing Treatments for Common Neurological Conditions Using Electronic Medical Records
Compares treatments for brain tumors, epilepsy, migraine and other neurological conditions in adults.
Plain-language title generated from the registry record
Registry title: Quality Improvement and Practice Based Research in Neurology Using the EMR
Key facts
- Where
- Evanston, United StatesSee the site
- Phase
- Phase 4
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Source: NCT02670161, who can take part
Where in United States
- NorthShore University HealthSystemEvanston, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Endeavor Health
- Trial code
- NCT02670161
- Record updated
- 24 August 2025
- Original description
The investigators will conduct at NorthShore University HealthSystem pragmatic trials using the EMR for 10 common neurological disorders. They will demonstrate the feasibility of subgroup based adaptive assignment of treatments, electronic consenting, and outcomes data capture at the point of care using the EMR. They will identify the most effective treatments for common neurological disorders and seek replication by the NPBRN.Read full original descriptionShow less
Quality Improvement and Practice Based Research in Neurology Using the Electronic Medical Record
The investigators will conduct at NorthShore University HealthSystem pragmatic trials using the EMR for 10 common neurological disorders. They will demonstrate the feasibility of subgroup based adaptive assignment of treatments, electronic consenting, and outcomes data capture at the point of care using the EMR. They will identify the most effective treatments for common neurological disorders and seek replication by the NPBRN.
Inclusion: Diagnosis of brain tumors, epilepsy, migraine, mild cognitive impairment (concussion), mild traumatic brain injury, multiple sclerosis, neuropathy, Parkinson's disease, restless legs syndrome, and stroke; Eligible to receive any of the three compared treatments according to FDA approval for the indication or off label use according to standard of care.
Exclusion: -- None.